An aplastic crisis is a sudden, temporary shutdown of red blood cell production in the bone marrow, causing a rapid and dangerous drop in hemoglobin. It almost always strikes people who already have a chronic blood disorder, particularly sickle cell disease or other hemolytic anemias, where the body depends on a high rate of red blood cell turnover to keep up with cells that are constantly being destroyed. When that production line halts, even for a few days, the results can be severe.
How an Aplastic Crisis Happens
The trigger in the vast majority of cases is parvovirus B19, the same virus that causes “fifth disease” (the mild rash illness common in young children). This virus has a very specific target: it infects erythroid progenitor cells, the precursor cells in the bone marrow that are in the process of becoming mature red blood cells. Once inside those cells, the virus hijacks their replication machinery during cell division and uses it to produce new copies of itself, killing the host cell in the process.
In a healthy person, this temporary disruption barely registers. Red blood cells live about 120 days, so a week or two of reduced production causes only a slight, unnoticeable dip in red blood cell levels. But in someone with sickle cell disease or another hemolytic anemia, red blood cells may survive only 10 to 20 days. Their bone marrow is already working overtime to replace cells that are breaking down rapidly. When parvovirus B19 knocks out production, the gap between destruction and replacement widens fast, and hemoglobin can plummet within days.
Who Is at Risk
Aplastic crisis occurs almost exclusively in people with conditions that shorten red blood cell lifespan or increase the body’s demand for new red blood cells. Sickle cell disease is the most commonly associated condition and the one most studied in this context. Other at-risk groups include people with hereditary spherocytosis, thalassemia, autoimmune hemolytic anemias, and other inherited red blood cell disorders.
In children with sickle cell disease, aplastic crisis tends to affect older children more than toddlers. People who are immunocompromised face a different but related problem: because their immune systems cannot clear the virus effectively, parvovirus B19 can cause prolonged or chronic suppression of red blood cell production rather than a single acute crisis.
Symptoms to Recognize
The hallmark symptoms are those of rapidly worsening anemia. Pallor is often the most visible sign, sometimes dramatic enough that family members notice it before the person feels unwell. Fatigue, weakness, and dizziness follow as hemoglobin drops. The heart compensates by beating faster (tachycardia), and you may notice a pounding heartbeat, shortness of breath with minimal exertion, or lightheadedness when standing.
Some people experience mild fever or flu-like symptoms in the days before the crisis becomes apparent. Unlike fifth disease in healthy children, the classic “slapped cheek” rash often does not appear in patients experiencing an aplastic crisis, which can make the viral trigger less obvious. In severe cases, the anemia can progress to heart failure if untreated, particularly in children or people with underlying heart conditions.
How It Is Diagnosed
Two lab findings together point strongly to an aplastic crisis. The first is a significant drop in hemoglobin compared to the person’s baseline. The second, and more telling, is a reticulocyte count below 1% to 3%. Reticulocytes are young, newly released red blood cells, and their count reflects how actively the bone marrow is producing. In someone with hemolytic anemia, the reticulocyte count is normally elevated because the marrow is working hard to compensate. A sudden drop to near zero signals that production has shut down.
This combination of worsening anemia plus absent reticulocyte production is what distinguishes an aplastic crisis from other emergencies in sickle cell disease. Blood tests for parvovirus B19 (either antibodies or viral DNA) can confirm the cause.
Aplastic Crisis vs. Splenic Sequestration
In young children with sickle cell disease, acute splenic sequestration can look similar at first glance because both involve a sudden drop in hemoglobin. The key differences are important for quick identification. In splenic sequestration, the spleen rapidly enlarges as it traps circulating blood, and the reticulocyte count is typically elevated because the bone marrow is still producing red blood cells normally. In an aplastic crisis, the spleen is not enlarged, and the reticulocyte count is abnormally low.
Splenic sequestration tends to occur in younger children (under 2 to 3 years), while aplastic crisis from parvovirus B19 is more common in older children and adults. Though considered mutually exclusive by their classical definitions, rare cases of both occurring simultaneously have been documented.
Treatment and Recovery
The primary treatment is supportive: red blood cell transfusion to bridge the gap until the bone marrow recovers on its own. Transfusion is generally recommended when hemoglobin falls below 7 g/dL, or at higher levels if the person is experiencing significant symptoms from the anemia. For people with sickle cell disease, the transfusion threshold may be adjusted based on their usual baseline hemoglobin.
The good news is that aplastic crisis is self-limiting. The immune system eventually clears the parvovirus, and the bone marrow resumes red blood cell production, typically within 7 to 10 days of the initial shutdown. As recovery begins, the reticulocyte count surges, sometimes dramatically, as the marrow ramps back up. Most people need only one or two transfusions to get through the crisis. Once the virus is cleared, infection with parvovirus B19 generally produces lifelong immunity, so a second aplastic crisis from the same virus is rare.
Contagion and Isolation
People in aplastic crisis are actively shedding parvovirus B19 and are contagious. This is different from healthy children with fifth disease, who are typically no longer contagious by the time the rash appears. Patients experiencing an aplastic crisis are considered infectious from before symptom onset and for at least one week afterward. In a hospital setting, this means droplet precautions and isolation from other vulnerable patients, particularly pregnant women (parvovirus B19 can cause serious complications in pregnancy) and other immunocompromised individuals.
The virus spreads through respiratory droplets, similar to a cold. Family members and close contacts who are pregnant or have their own blood disorders should be informed of the exposure so they can be monitored.